Denvax Cellular Therapies Private Limited

Provides safe and effective dendritic cell treatment for cancer patients through innovative technology.

2009 | New Delhi, Delhi (India) | Active
Last Updated:

Denvax Cellular Therapies Profile

Key Indicators

  • Authorised Capital ₹ 1.10 Cr
  • Paid Up Capital ₹ 1.10 Cr
  • Company Age 15 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth -16.35%
  • Ebitda -16.67%
  • Net Worth 3.86%
  • Total Assets %

About Denvax Cellular Therapies

Denvax Cellular Therapies Private Limited (DCTPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 July 2009 and has a history of 15 years and seven months. Its registered office is in New Delhi, Delhi, India.

The Company is engaged in the Packaging Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.

Arun Mehra, Anita Mehra, Sanjiv Jain, and One other member serve as directors at the Company.

Company Details

  • Location

    New Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    denvax.in

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U85191DL2009PTC192776

  • Company No.

    192776

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    31 Jul 2009

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Packaging

Who are the key members and board of directors at Denvax Cellular Therapies?

Board Members (4)

NameDesignationAppointment DateStatus
Arun Mehra Country flag representing In Director 31-Jul-2009Current
Anita Mehra Country flag representing In Director 31-Jul-2009Current
Sanjiv Jain Country flag representing In Director 31-Jul-2009Current
Anju Jain Country flag representing In Director 31-Jul-2009Current

Financial Performance of Denvax Cellular Therapies.

Denvax Cellular Therapies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 16.35% decrease in profit. The company's net worth moved up by a moderate rise of 3.86%.

Denvax Cellular Therapies revenue growth over time
Denvax Cellular Therapies profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
-16.35%
Net Worth
3.86%
EBITDA
-16.67%

What is the Ownership and Shareholding Structure of Denvax Cellular Therapies?

In 2023, Denvax Cellular Therapies had a promoter holding of 97.64% and a public holding of 2.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Denvax Cellular Therapies?

Unlock and access historical data on people associated with Denvax Cellular Therapies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Denvax Cellular Therapies Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Denvax Cellular Therapies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Denvax Cellular Therapies's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Denvax Cellular Therapies

Recent activity within the organization

  • Annual General Meeting

    Denvax Cellular Therapies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Denvax Cellular Therapies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Director Appointment

    Arun Mehra was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 15 years 7 months .

  • Director Appointment

    Anita Mehra was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 15 years 7 months .

  • Director Appointment

    Sanjiv Kumar Jain was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 15 years 7 months .

  • Director Appointment

    Anju Sanjiv Kumar Jain was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 15 years 7 months .

Frequently asked questions

  • What is the Incorporation or founding date of Denvax Cellular Therapies Private Limited?

    Denvax Cellular Therapies Private Limited was incorporated on 31 Jul 2009.

  • What is authorized share capital and paid-up capital of Denvax Cellular Therapies Private Limited?

    The authorized share capital of Denvax Cellular Therapies Private Limited is ₹ 1.10 Cr and paid-up capital is ₹ 1.10 Cr.

  • Who are the current board members & directors of Denvax Cellular Therapies Private Limited?

    Currently 4 directors are associated with Denvax Cellular Therapies Private Limited.

    • Arun Mehra
    • Anita Mehra
    • Sanjiv Kumar Jain
    • Anju Sanjiv Kumar Jain
  • What is the registered address of Denvax Cellular Therapies Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Denvax Cellular Therapies Private Limited is Kh.N.-153-B Western Avenue Sainik Farm Near Bses Transformer, New Delhi, India, 110062.

  • What is the corporate identification number (CIN) and company number of Denvax Cellular Therapies Private Limited?

    The corporate identification number (CIN) of Denvax Cellular Therapies Private Limited is U85191DL2009PTC192776 and the company number is 192776 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Denvax Cellular Therapies Private Limited?

    The Official website of Denvax Cellular Therapies Private Limited is https://www.denvax.in

  • What change has been observed in the net worth of Denvax Cellular Therapies Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Denvax Cellular Therapies Private Limited has experienced an upsurge of 3.86%.

  • When was the last Balance Sheet of Denvax Cellular Therapies Private Limited filed with the ROC?

    The most recent Balance Sheet for Denvax Cellular Therapies Private Limited was filed with the ROC on 31 Mar 2023.